Entegris Operating Cash Flow decreased by 4.7% to $183.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.3%, from $140.40M to $183.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 14.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $81.86M | $149.50M | $115.98M | $63.79M | $110.91M | $145.53M | $42.90M | $151.87M | $127.02M | $207.48M | $158.13M | $147.20M | $111.20M | $197.20M | $176.10M | $140.40M | $113.50M | $249.50M | $192.00M | $183.00M |
| QoQ Change | — | +82.6% | -22.4% | -45.0% | +73.9% | +31.2% | -70.5% | +254.0% | -16.4% | +63.3% | -23.8% | -6.9% | -24.5% | +77.3% | -10.7% | -20.3% | -19.2% | +119.8% | -23.0% | -4.7% |
| YoY Change | — | — | — | — | +35.5% | -2.7% | -63.0% | +138.1% | +14.5% | +42.6% | +268.6% | -3.1% | -12.5% | -5.0% | +11.4% | -4.6% | +2.1% | +26.5% | +9.0% | +30.3% |